MichaelEzekowitzMD
Cardiology • Bryn Mawr, PACardiac Electrophysiology, Echocardiography, Non-Invasive Cardiology
Physician
Dr. Ezekowitz is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
830 Old Lancaster Rd
Ste 301
Bryn Mawr, PA 19010Phone+1 610-389-7626Fax+1 610-525-2114
Education & Training
University of Cape Town Faculty of MedicineClass of 1970
Certifications & Licensure
PA State Medical License 2000 - 2024
CT State Medical License 1982 - 2002
MD State Medical License 1977 - 1988
OK State Medical License 1978 - 1988- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Cardiovascular Disease
Awards, Honors, & Recognition
- Fellow (FACC) American College of Cardiology
Clinical Trials
- Efficacy and Safety Study of an Antiarrhythmic Drug to Treat Atrial Fibrillation in Patients With Pacemakers Start of enrollment: 2006 Jul 01
- Phase 2 Study of the Safety, Tolerability and Pilot Efficacy of Oral Factor Xa Inhibitor Betrixaban Compared to Warfarin Start of enrollment: 2008 Oct 01
Publications & Presentations
PubMed
- 7834 citationsDabigatran versus warfarin in patients with atrial fibrillationStuart J. Connolly, Michael D. Ezekowitz, John W. Eikelboom, Jonas Oldgren, Amit Parekh
The New England Journal of Medicine. 2009-12-10 - 762 citationsEfficacy and safety of dabigatran compared with warfarin at different levels of international normalised ratio control for stroke prevention in atrial fibrillation: An...Lars Wallentin, Salim Yusuf, Michael D. Ezekowitz, Marco Alings, Marcus Flather
Lancet. 2010-09-18 - 3494 citationsEdoxaban versus warfarin in patients with atrial fibrillationRobert P. Giugliano, Christian T. Ruff, Eugene Braunwald, Sabina A. Murphy, Stephen D. Wiviott
The New England Journal of Medicine. 2013-11-27
Journal Articles
- Original Investigation Concomitant Oral Anticoagulant and Nonsteroidal Anti-Inflammatory Drug Therapy in Patients with Atrial FibrillationMichael Ezekowitz, MD, ScienceDirect
- Concomitant Oral Anticoagulant and Nonsteroidal Anti-Inflammatory Drug Therapy in Patients with Atrial FibrillationMichael Ezekowitz, MD, JACC: Cardiovascular Imaging
- Choosing a Particular Oral Anticoagulant and Dose for Stroke Prevention in Individual Patients with Non-Valvular Atrial Fibrillation: Part 1Jonathan L Halperin, Elaine M Hylek, Michael D Ezekowitz, James Aisenberg, European Heart Journal
Lectures
- Highlights in Anti-Coagulation2019 ACC Scientific Session & Expo, New Orleans - 3/18/2019
- NOACs Post Cardioversion and Atrial Appendage Occlusion/Exclusion2019 ACC Scientific Session & Expo, New Orleans - 3/18/2019
- Engage @ACC.19 Studio: Cardiology Contest2019 ACC Scientific Session & Expo, New Orleans - 3/16/2019
Press Mentions
ESC: Apixaban Bests Heparin in Cardioversion TreatmentAugust 30th, 2017
Merican Heart Association/American College of Physicians Ask Force on Clinical Competence and TrainingOctober 3rd, 2006
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
